Searchable abstracts of presentations at key conferences in endocrinology

ea0038p228 | Obesity, diabetes, metabolism and cardiovascular | SFEBES2015

Characterising fat distribution and response to weight loss in idiopathic intracranial hypertension

Ali Fizzah , O'Reilly Michael , Botfield Hannah , Markey Keira , Tomlinson Jeremy , Arlt Wiebke , Sinclair Alexandra

Introduction: Idiopathic intracranial hypertension (IIH) occurs in young obese women (>90%) but little is known about the metabolic characteristics in these patients. We aimed to characterise IIH fat distribution, metabolic phenotype and evaluate alterations following weight loss.Methods: IIH and matched (BMI/sex) healthy obese controls were recruited. Metabolic indices (fasting lipid, glucose, insulin), anthropological measures and body composition ...

ea0038p249 | Obesity, diabetes, metabolism and cardiovascular | SFEBES2015

Impact of DAFNE and subsequent CSII therapy on glycaemic control in type 1 diabetes mellitus

Yunus Saba , Forde Hannah , Browne Sonya , Twamley Helen , Fanning Eimear , Smith Diarmuid

Background: Dose adjustment for normal eating (DAFNE) structured education programme is an effective tool in improving glycaemic control in patients with type 1 diabetes while reducing the frequency of hypoglycemic episodes. DAFNE however, does not solve all glucose related problems and patients often request or are recommended continuous subcutaneous insulin infusion (CSII) therapy post DAFNE.Objective: Out of our 370 DAFNE graduates, 46 have subsequent...

ea0038p278 | Obesity, diabetes, metabolism and cardiovascular | SFEBES2015

Comparison of glycaemic control in patients with type-1 diabetes mellitus on CSII therapy with different basal rates

Yunus Saba Yunus , Forde Hannah , Browne Sonya , Moore Anne , Fanning Eimear , Smith Diarmuid

Background: There are very few studies comparing glycaemic control in patients with different basal rates on Continuous Subcutaneous Insulin Infusion therapy (CSII), so the ideal number of basal rates for a patient is not clear.Objective: To compare the glycaemic control between patients with different basal rates.Methods: Data were collected from hospital’s database and by contacting patients via phone....

ea0034p111 | Clinical practice/governance and case reports | SFEBES2014

A rare case of Cushing's syndrome caused by ‘cyclical’ ectopic ACTH secretion

Behary Preeshila , Kadiyala Raghunath , Falinska Agnieszka , Beckwith Hannah , Jackson James , Mitchell Catherine , Todd Jeannie F

A 61-year-old lady presented with rapid onset of lethargy and reduced mobility with inability to use stairs over 1 month. Prior to this, she was fit and well and was a lifelong non-smoker. At presentation, she was overweight and had evidence of skin bruising and severe proximal myopathy of her legs. A midnight cortisol was >1710 nmol/l with a corresponding ACTH of 610 nmol/l confirming ACTH dependent Cushing’s syndrome. Serum potassium was 2.6 mmol/l and a new diagnos...

ea0034p390 | Thyroid | SFEBES2014

Factors contributing to high levothyroxine doses in primary hypothyroidism; an interventional audit of a large community database

Robertson Hannah , Narayanaswamy Anil , Pereira Olivia , Copland Shirley , Herriot Richard , McKinlay Alastair , Bevan John , Abraham Prakash

Background: While few hypothyroid patients require more than the expected weight related dose of levothyroxine, the underlying causes of larger-than-expected dosing requirements have not been studied in a single cohort. Our aim was to determine and quantify the multiple factors contributing to high dose levothyroxine requirements in a cohort of patients with hypothyroidism.Methods: The Grampian Automated Follow-Up Register (GAFUR) monitors around 17 500 ...

ea0070oc1.7 | Adrenal and Cardiovascular Endocrinology | ECE2020

Comparative proteomic analysis of different bilateral adrenocortical hyperplasia

Berthon Annabel , Cologna Stephanie , Blank Paul , Hannah-Shmouni Fady , Bertherat Jerome , Porter Forbes , Stratakis Constantine

Bilateral Adrenal Hyperplasias (BAH) are responsible for approximately 10% of ACTH-independent Cushing syndrome and are classified as either micronodular or macronodular. Whereas Primary Pigmented Nodular Adrenocortical Disease (PPNAD) and isolated Micronodular Adrenal Disease (iMAD) are two types of micronodular hyperplasia, Primary Macronodular Adrenal Hyperplasia (PMAH) is a macronodular BAH. These tumors are classified differently based on clinical, histological and geneti...

ea0033oc3.4 | Oral Communications 3 | BSPED2013

Successful Use of Long Acting Octreotide in Treatment of Congenital Hyperinsulinism

Shah Pratik , Gilbert Clare , Morgan Kate , Hinchey Louise , Senniappan Senthil , Arya Ved , Levy Hannah , Hussain Khalid

Introduction/Aim: Congenital hyperinsulinism (CHI) is a cause of severe hypoglycaemia in infancy. Treatment of diazoxide unresponsive patients includes the use of somatostatin analogues (octreotide given either as four s.c. injections daily or via a pump). We aimed to evaluate the use of a long acting somatostatin analogue (Lanreotide) in children with CHI, switching them from daily oral diazoxide or s.c. Octreotide injections to 4 weekly Lanreotide injections.<p class="ab...

ea0028p229 | Obesity, diabetes, metabolism and cardiovascular | SFEBES2012

A putative role for amino acids in appetite regulation

McGavigan Anne , Greenwood Hannah , Kinsey-Jones James , Ghatei Mohammed , Bloom Stephen , Murphy Kevin

Obesity is a major worldwide health problem with limited treatment options. Recent research has highlighted the importance of gastrointestinal (GI) nutrient sensing in the regulation of food intake and metabolism. Protein as a macronutrient induces the strongest feeling of satiety per calorie. However, different types of protein have varying effects on appetite, suggesting protein induced satiety may be due to the specific amino acids generated by protein digestion. We have id...

ea0025oc4.8 | Bone and diabetes | SFEBES2011

Hyperghrelinaemia, hyperphagia, food hoarding and reduced adiposity in an imprinting centre deletion mouse model of Prader–Willi syndrome

Wells Timothy , Relkovic Dinko , Furby Hannah , Guschina Irina , Nishimura Sachiko , Resnick James , Isles Anthony

Prader–Willi syndrome (PWS) is a neurodevelopmental disorder caused by a lack of paternal gene expression from 15q11–q13 and is characterised by failure to thrive in infancy, followed by hyperphagia due to abnormal satiety responses and increased motivation by food. We investigated growth and metabolism a mouse model in which the imprinting centre (IC) of the homologous PWS interval has been deleted (PWS-IC mice). Growth retardation only emerged post-natally, with ad...

ea0015p98 | Clinical practice/governance and case reports | SFEBES2008

Biochemical diagnosis of sporadic phaeochromocytoma: an audit of 24 h urinary catecholamine excretion (UCAT) requests from primary and secondary care

Leelarathna Lalantha , Owen Lisa , Bailey Stephanie , Bainbridge Hannah , Iversen Andrew , Crown Anna

Objectives: The audit was carried out to inform the development of a local protocol for investigation of patients with suspected sporadic phaeochromocytoma.Method: Details of all UCAT tests performed in 2006 for a catchment area of approximately 500 000 were obtained.Questionnaires were used to obtain further information about all the patients referred from primary care and secondary care patients with UCAT > upper limit of nor...